Marc Tian Selected Research

Interleukin Inhibitors

1/2021	Switch rates and total cost associated with apremilast and biologics in biologic-naive patients with psoriatic arthritis.
1/2020	Switch Rates and Total Cost of Care Associated with Apremilast and Biologic Therapies in Biologic-Naive Patients with Plaque Psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Tian Research Topics

Disease

5	Multiple Sclerosis 12/2021 - 01/2020
3	Psoriatic Arthritis 01/2021 - 01/2020
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 04/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2021

Drug/Important Bio-Agent (IBA)

6	Biological ProductsIBA 01/2021 - 04/2019
6	apremilastIBA 01/2021 - 04/2019
2	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 01/2020
2	Interleukin InhibitorsIBA 01/2021 - 01/2020
1	Rituximab (Mabthera)FDA Link 12/2021
1	Monoclonal AntibodiesIBA 12/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	InterleukinsIBA 01/2020

Therapy/Procedure

6	Therapeutics 12/2021 - 04/2019
1	Biological Therapy 01/2020